There is another MNK1 inhibitor, CG957380, abrogating rapalogs-induced EIF4E phosphorylation and AKT activation and increase apoptosis to inhibit growth of NSCLC in vitro and in vivo27. The gene discussed is MKNK1; the disease is non-small cell lung carcinoma.